Cite
HARVARD Citation
Jimenez‐Yuste, V. et al. (2022). Efficacy and safety evaluation of Fanhdi®, a plasma‐derived factor VIII/ von Willebrand factor concentrate, in Von Willebrand's disease patients undergoing surgery or invasive procedures: A prospective clinical study. Haemophilia. 28 (1), pp. e23-e27. [Online].